IS3378A7 - 1,4 - Dihydropyridines, og aðferð við framleiðslu þess svo og notkun þess í lækningaskyni - Google Patents

1,4 - Dihydropyridines, og aðferð við framleiðslu þess svo og notkun þess í lækningaskyni

Info

Publication number
IS3378A7
IS3378A7 IS3378A IS3378A IS3378A7 IS 3378 A7 IS3378 A7 IS 3378A7 IS 3378 A IS3378 A IS 3378A IS 3378 A IS3378 A IS 3378A IS 3378 A7 IS3378 A7 IS 3378A7
Authority
IS
Iceland
Prior art keywords
methyl
dihydropyridines
manufacture
well
therapeutic use
Prior art date
Application number
IS3378A
Other languages
English (en)
Other versions
IS1549B (is
Inventor
Fernandez Torija Carlos
Alvaro Galiano Ramos Joaquin
Original Assignee
Almirall-Prodesfarma, S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Almirall-Prodesfarma, S.A. filed Critical Almirall-Prodesfarma, S.A.
Publication of IS3378A7 publication Critical patent/IS3378A7/is
Publication of IS1549B publication Critical patent/IS1549B/is

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cardiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
IS3378A 1987-08-03 1988-08-02 1,4 - Dihydropyridines, og aðferð við framleiðsluþess svo og notkun þess í lækningaskyni IS1549B (is)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP87401799A EP0302980B1 (fr) 1987-08-03 1987-08-03 1,4-Dihydropyridines, leur procédé de préparation et leur application comme médicaments

Publications (2)

Publication Number Publication Date
IS3378A7 true IS3378A7 (is) 1989-02-04
IS1549B IS1549B (is) 1994-06-08

Family

ID=8198243

Family Applications (1)

Application Number Title Priority Date Filing Date
IS3378A IS1549B (is) 1987-08-03 1988-08-02 1,4 - Dihydropyridines, og aðferð við framleiðsluþess svo og notkun þess í lækningaskyni

Country Status (34)

Country Link
US (1) US4952592A (is)
EP (1) EP0302980B1 (is)
JP (1) JPH0733383B2 (is)
KR (1) KR960001724B1 (is)
CN (1) CN1038587C (is)
AT (1) ATE61588T1 (is)
BE (1) BE1001055A4 (is)
CA (2) CA1306261C (is)
CH (1) CH675999A5 (is)
CZ (1) CZ282077B6 (is)
DD (1) DD282008A5 (is)
DE (2) DE3768658D1 (is)
DK (1) DK430288A (is)
ES (1) ES2007543A6 (is)
FI (1) FI91406C (is)
GB (1) GB2208861B (is)
GR (2) GR880100507A (is)
HU (1) HU204523B (is)
IE (1) IE60358B1 (is)
IL (1) IL87321A (is)
IN (1) IN167550B (is)
IS (1) IS1549B (is)
IT (1) IT1235013B (is)
LU (1) LU87297A1 (is)
MA (1) MA21344A1 (is)
NO (1) NO170934C (is)
NZ (1) NZ225661A (is)
PH (1) PH25645A (is)
PT (1) PT88173B (is)
RU (1) RU2036922C1 (is)
SK (1) SK278775B6 (is)
TN (1) TNSN88081A1 (is)
YU (1) YU46547B (is)
ZA (1) ZA885684B (is)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5242933A (en) * 1990-07-10 1993-09-07 Adir Et Compagnie Piperidine, tetrahydropyridine and pyrrolidine compounds
US5942516A (en) * 1995-08-02 1999-08-24 Elliott; John Duncan Endothelin receptor antagonists
RU2168987C2 (ru) * 1997-04-15 2001-06-20 Санкт-Петербургская Государственная Химико-Фармацевтическая Академия Гипотензивное средство
RU2155036C2 (ru) * 1998-11-11 2000-08-27 Азад Зияд Оглы Абышев Средство для лечения ишемической болезни сердца
IT1304513B1 (it) * 1998-12-30 2001-03-19 Endura Spa Processo per la sintesi di 5-(alfa-idrossialchil)benzo(1,3)diossoli.
DE60128683T2 (de) * 2000-04-11 2008-01-24 Sankyo Co., Ltd. Stabilisierte pharmazeutische zusammenstellungen die den calziumkanalblocker azelnidipine enthalten
RU2187303C2 (ru) * 2000-10-12 2002-08-20 Азад Зияд Оглы Абышев Способ получения таблеток диуманкала - forte по 0,01 г
CN1681495B (zh) 2002-08-19 2010-05-12 辉瑞产品公司 用于治疗过度增生性疾病的组合物
CA2574958A1 (en) * 2004-07-26 2006-02-09 Cotherix, Inc. Treatment of pulmonary hypertension by inhaled iloprost with a microparticle formulation
US7741317B2 (en) 2005-10-21 2010-06-22 Bristol-Myers Squibb Company LXR modulators
EP2351569B1 (en) 2005-10-26 2012-08-22 Asahi Kasei Pharma Corporation Fasudil in combination therapies for the treatment of pulmonary arterial hypertension
JP2009513660A (ja) * 2005-10-26 2009-04-02 旭化成ファーマ株式会社 肺動脈性高血圧の治療用併用療法におけるファスジル
US7888376B2 (en) 2005-11-23 2011-02-15 Bristol-Myers Squibb Company Heterocyclic CETP inhibitors
TW200736245A (en) * 2005-11-29 2007-10-01 Sankyo Co Acid addition salts of optically active dihydropyridine derivatives
TW200806648A (en) * 2005-11-29 2008-02-01 Sankyo Co Acid addition salts of dihydropyridine derivatives
US7919506B2 (en) 2006-03-10 2011-04-05 Pfizer Inc. Dibenzyl amine compounds and derivatives
US8404896B2 (en) 2006-12-01 2013-03-26 Bristol-Myers Squibb Company N-((3-benzyl)-2,2-(bis-phenyl)-propan-1-amine derivatives as CETP inhibitors for the treatment of atherosclerosis and cardiovascular diseases
WO2012037665A1 (en) 2010-09-24 2012-03-29 Oral Delivery Technology Ltd. Nitric oxide releasing amino acid ester for treatment of pulmonary hypertension and other respiratory conditions
BR112015026513A2 (pt) 2013-04-17 2017-07-25 Pfizer derivados de n-piperidin-3-ilbenzamida para tratar as doenças cardiovasculares
WO2016055901A1 (en) 2014-10-08 2016-04-14 Pfizer Inc. Substituted amide compounds
RS66416B1 (sr) 2019-01-18 2025-02-28 Astrazeneca Ab 6'-[[(1s,3s)-3-[[5-(difluorometoksi)-2-pirimidinil]amino]ciklopentil]amino][1(2h),3'-bipiridin]-2-on kao inhibitor pcsk9 i metode njegove primene

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3441648A (en) * 1967-02-07 1969-04-29 Smithkline Corp Compositions and methods for lowering blood pressure with 1,4-dihydropyridines
US4031104A (en) * 1972-04-18 1977-06-21 Bayer Aktiengesellschaft 1,4-Dihydropyridine carboxylic acid esters
JPS5978186A (ja) * 1982-10-27 1984-05-04 Yoshitomi Pharmaceut Ind Ltd １，４−ジヒドロピリジン−３，５−ジカルボン酸エステル誘導体
IE57810B1 (en) * 1984-03-27 1993-04-21 Delagrange Lab 1,4-dihydropyridine derivatives,their preparation and their use
ES531033A0 (es) * 1984-03-27 1985-09-01 Inst Investigacion Desarrollo Un procedimiento para la preparacion de nuevas 1,4-dihidropirinas-4-(polioxialquilfenil)-sustituidas
JPH068294B2 (ja) * 1985-02-26 1994-02-02 富山化学工業株式会社 新規な１，４−ジヒドロピリジン誘導体およびその塩
EP0174131A3 (en) * 1984-09-01 1989-06-07 FISONS plc Dihydropyridines, processes and intermediates for their production, and pharmaceutical formulations containing them
JPH01207267A (ja) * 1987-03-05 1989-08-21 Yamanouchi Pharmaceut Co Ltd ピリジン誘導体及び該化合物を含有する肝疾患治療剤

Also Published As

Publication number Publication date
KR890003743A (ko) 1989-04-17
IL87321A (en) 1993-04-04
FI91406B (fi) 1994-03-15
JPH0733383B2 (ja) 1995-04-12
PT88173B (pt) 1995-03-01
EP0302980B1 (fr) 1991-03-13
FI883603A0 (fi) 1988-08-01
RU2036922C1 (ru) 1995-06-09
DE3825962A1 (de) 1989-02-16
IT8848259A0 (it) 1988-08-02
CA1306262C (fr) 1992-08-11
PH25645A (en) 1991-08-21
GR880100507A (el) 1989-05-25
DK430288D0 (da) 1988-08-02
IE882364L (en) 1989-02-03
AU606441B2 (en) 1991-02-07
FI883603A7 (fi) 1989-02-04
ZA885684B (en) 1989-04-26
DK430288A (da) 1989-02-03
GB2208861B (en) 1991-07-17
JPH01294675A (ja) 1989-11-28
IS1549B (is) 1994-06-08
GB8818356D0 (en) 1988-09-07
IN167550B (is) 1990-11-10
YU147088A (en) 1990-04-30
ES2007543A6 (es) 1989-06-16
EP0302980A1 (fr) 1989-02-15
AU2033088A (en) 1989-02-09
US4952592A (en) 1990-08-28
GB2208861A (en) 1989-04-19
CZ282077B6 (cs) 1997-05-14
IE60358B1 (en) 1994-06-29
NO883406L (no) 1989-02-06
FI91406C (fi) 1994-06-27
CN1031531A (zh) 1989-03-08
PT88173A (pt) 1989-06-30
HU204523B (en) 1992-01-28
NZ225661A (en) 1990-08-28
GR3001984T3 (en) 1992-11-23
IT1235013B (it) 1992-06-16
BE1001055A4 (fr) 1989-06-20
YU46547B (sh) 1993-11-16
NO170934B (no) 1992-09-21
SK541388A3 (en) 1998-02-04
CN1038587C (zh) 1998-06-03
CA1306261C (fr) 1992-08-11
KR960001724B1 (ko) 1996-02-03
TNSN88081A1 (fr) 1990-07-10
CH675999A5 (en) 1990-11-30
ATE61588T1 (de) 1991-03-15
SK278775B6 (sk) 1998-02-04
CZ541388A3 (en) 1997-01-15
HUT54142A (en) 1991-01-28
LU87297A1 (fr) 1989-02-02
MA21344A1 (fr) 1989-04-01
IL87321A0 (en) 1989-01-31
NO170934C (no) 1992-12-30
NO883406D0 (no) 1988-08-01
DD282008A5 (de) 1990-08-29
DE3768658D1 (de) 1991-04-18

Similar Documents

Publication Publication Date Title
IS1549B (is) 1,4 - Dihydropyridines, og aðferð við framleiðsluþess svo og notkun þess í lækningaskyni
EA199700209A1 (ru) ПРОИЗВОДНЫЕ ИМИДАЗО[1,2-a]ПИРИДИНА
NO963506L (no) 4-Heterocyklyl-substituerte kinazolin-derivater, fremgangsmåte for fremstilling derav og deres anvendelse som anti-kreftmidler
FI900307A0 (fi) Menetelmä valmistaa terapeuttisesti aktiivista 3-/3-okso-(2,3)-dihydropyridatsin-6-yyli/-2-fenyyli-pyratsolo/1,5-a/pyridiinijohdannaisia
DK84088A (da) Naphthalenderivater med anvendelse som antiallergiske og antiinflammatoriske midler
HUT47580A (en) Process for production of tricycle oxindole derivatives decreasing inflammation
FI99013B (fi) Analogiamenetelmä terapeuttisesti käyttökelpoisten bentsimidatsolijohdannaisten valmistamiseksi
DE3566263D1 (de) Novel cyanoimidazole nucleoside derivatives
FI810103L (fi) Nya 2,3-dihydro-imidazo /1,2-b/ pyridazinderivat foerfarande foer deras framstaellning och deras terapeutiska anvaendning
SE8605255L (sv) 4h-benso(4,5)cyklohepta(1,2-b)tiofen-derivat
NO176277C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive 3,4-dihydro-2-alkyl-3-okso-N-aryl-2H-[1Åbenzotieno[3,2-eÅ-1,2-tiazin-4-karboksamid-1,1-dioksyder
HUT45255A (en) Process for producing furo/3,4-b/pyridine derivatives and pharmaceutical compositions comprising these compounds
PL293117A1 (en) Method of obtaining substituted alkenic acid and its derivatives
DE3889532D1 (de) Dihydropyridin-Verbindung zur Verbesserung der Adernausdehnung und Hemmung der Herzhypertrophie.
PT83883A (en) Process for the preparation of 4h-benzo]4,5"cyclohepta]1,2-b"thiophene derivatives
PT79509A (en) Method for preparing diphenylsulfide derivatives